Back to Search Start Over

LBA7Afatinib followed by osimertinib in patients with EGFR mutation-positive advanced NSCLC: A real-world study (GioTag).

Authors :
Hochmair, M J
Morabito, A
Hao, D
Yang, C-T
Soo, R A
Yang, J C-H
Gucalp, R
Halmos, B
Wang, L
Golembesky, A
Source :
Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.
Publication Year :
2018

Subjects

Subjects :
*SQUAMOUS cell carcinoma

Details

Language :
English
ISSN :
09237534
Volume :
29
Database :
Academic Search Index
Journal :
Annals of Oncology
Publication Type :
Academic Journal
Accession number :
133479278
Full Text :
https://doi.org/10.1093/annonc/mdy483.006